300+ investors in your industry, stage, and region Get
Any industry
Artificial Intelligence
Google
EdTech
Clean Energy
Retail
Enterprise Software
Local
Travel
Platforms
InsurTech
Oil and Gas
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Renewable Energy
Organic Food
Email
Fitness
CleanTech
Energy
Health Care
Machine Learning
Agriculture (AgTech)
Marketplace
Gaming
Facebook
Blockchain
Social Network
B2B
Big Data
Video Games
Education
Wellness
Medical Device
Mobile
Legal
Sports
Construction
Automotive
eSports
Hospitality
Biotechnology
Consumer
Software
Crowdfunding
Venture Capital
Social
Infrastructure
Fashion
Beauty
LGBT
Celebrity
Cannabis
Climate
Mobile Apps
Life Science
Publishing
Food and Beverage
Wine and Spirits
Real Estate
Sporting Goods
Art
Music
Finance
Digital Media
FinTech
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Mobile Advertising
Internet
Android
Impact
Biotech
Proptech
Sustainability
Hardware
Transportation
Enterprise
Community
Media (Entertainment)
Web3
Medical
Theatre
Recruiting
Any country
South Korea
Africa
Oceania
Brazil
Saudi Arabia
Singapore
LATAM
Greece
Gibraltar
Norway
Liberia
Mexico
Taiwan
Sweden
Zambia
Puerto Rico
Nigeria
Isle of Man
Pakistan
Romania
Tunisia
Russian Federation
Togo
Tajikistan
Zimbabwe
Cameroon
Oman
India
Colombia
Australia
New Zealand
China
Sri Lanka
Vietnam
Armenia
Costa Rica
Chile
Switzerland
Czech Republic
Kenya
Cayman Islands
Kuwait
Kazakhstan
Jamaica
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uganda
Turkey
Uzbekistan
Venezuela
Guatemala
Seychelles
Japan
Germany
United Kingdom
Canada
Ireland
South Africa
Egypt
France
Georgia
Denmark
Croatia
Hong Kong
Ghana
Iraq
Mali
Morocco
Myanmar
Latvia
Malaysia
Portugal
Philippines
Poland
Rwanda
Sierra Leone
Senegal
Thailand
El Salvador
Uruguay
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Cyprus
Qatar
United Arab Emirates
Spain
Angola
Europe
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Bahrain
Bahamas
Estonia
Faroe Islands
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Iceland
Cambodia
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Life Science Startup Investors in Belgium (June 2026)

The most active venture capital funds and angel investors investing in Belgium Life Science startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Belgium Life Science startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Meusinvest (Noshaq)
VC Fund
6 Belgium, France, Germany Series A, Seed Biotechnology, Health Care, Medical $137k–$16M
PMV
VC Fund
5 Belgium, United States, The Netherlands Series A, Seed Software, Biotechnology, Health Care $549k–$40M
Qbic Fund
VC Fund
4 Belgium, The Netherlands Seed, Series A Biotechnology, Software, Health Care $868k–$47M
Limburgse Reconversie Maatschappij
VC Fund
3 Belgium, United States, The Netherlands Seed, Series A Information Technology, Software, Biotechnology $494k–$11M
Sambrinvest
VC Fund
3 Belgium, France, Spain Seed, Series A, Series B Biotechnology, Health Care, Medical $411k–$57M
S.R.I.W.
VC Fund
3 Belgium, United States, Spain Series A, Series B Health Care, Biotechnology, Manufacturing $411k–$75M
Theodorus III
VC Fund
3 Belgium, Canada, France Seed, Series A Health Care, Life Science, Medical $2.2M–$11M
V-Bio Ventures
VC Fund
2 Belgium, France, United States Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $3.2M–$88M
Mérieux Equity Partners
VC Fund
2 France, United States, Belgium Series A, Private Equity Health Care, Biotechnology, Medical Device $5.8M–$150M
Annie Vereecken
Angel
2 Belgium Seed, Series A Medical, Biotechnology, Hospital $2M–$27M
Innovation Fund
VC Fund
2 Belgium, France, Luxembourg Seed, Series A Health Care, Manufacturing, Information Technology $329k–$5.8M
Pierre Drion
Angel
2 Belgium Series A, Series B Biotechnology, Health Care, Life Science $8.8M–$26M
VIB
VC Fund
2 Belgium, Brazil, Denmark Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $3.2M–$84M
New Science Ventures
VC Fund
2 United States, United Kingdom, Belgium Series B, Series A Biotechnology, Health Care, Medical $4M–$52M
Luc Vauterin
Angel
2 Belgium Seed, Series A Life Science, Data Integration, Data Visualization
Industrya
VC Fund
1 France, Belgium Seed, Series A Industrial, B2B, SaaS $1.1M–$6.7M
Piet Van Waes
Angel
1 Belgium Seed, Pre-Seed Hotel, Medical, Tourism $1M–$2.4M
Jürgen Ingels
Angel
1 Belgium, Turkey, The Netherlands Seed, Series B, Series A Software, Analytics, SaaS $2.4M–$35M
Sofinnova Investments
VC Fund
1 United States, France, Switzerland Series B, Series A, Series C Biotechnology, Health Care, Pharmaceutical $7.3M–$137M
Evren Ucok
Angel
1 Turkey, Belgium Series A Medical, Health Care, Life Science
6K Venture Capital
VC Fund
1 Panama, Belgium Seed, Series A Medical, Software, Health Care
Capricorn Partners
VC Fund
1 Belgium, United States, The Netherlands Series A, Series B Biotechnology, Software, Health Care $3.3M–$42M
OBI SA
VC Fund
1 Belgium Life Science, Biotechnology, Health Diagnostics
Fund+
VC Fund
1 Belgium, United States, Spain Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $11M–$401M
BioGeneration Ventures
VC Fund
1 The Netherlands, United States, Belgium Series A, Seed Biotechnology, Therapeutics, Health Care $1.1M–$86M
invest.bw
VC Fund
1 Belgium, United States Seed, Pre-Seed, Series A Biotechnology, Manufacturing, Farming $2.9M–$43M
Qbic
VC Fund
1 Belgium Seed, Series B Health Care, Biotechnology, AgTech
Ifoghas Investments
VC Fund
1 Belgium Series A Medical, Health Care, Life Science
Nausicaa Ventures
VC Fund
1 Belgium Series B Software, CRM, Big Data
Fonds Vives II (University of Louvain, UCL)
VC Fund
1 Belgium, United States Series A, Series B, Seed Biotechnology, Health Care, Medical $6.6M–$75M
Vives Louvain Technology Fund
VC Fund
1 Belgium, France, United States Series A, Series B Health Care, Biotechnology, Medical $491k–$125M
Annemie Van de Casteele
Angel
1 Belgium Seed Medical, Life Science, Biotechnology
Virginie Saverys
Angel
1 Belgium Seed Medical, Life Science, Biotechnology
Griet Nuytinck
Angel
1 Belgium Seed Medical, Life Science, Biotechnology
Opdorp Finance BVBA
VC Fund
1 Belgium Series A Life Science, Data Integration, Data Visualization
Korys
VC Fund
1 Belgium, The Netherlands, Germany Series B, Series A Biotechnology, Renewable Energy, Information Technology $3.9M–$110M
Smedvig
VC Fund
1 Belgium, Romania, South Africa Series A, Series C Mining, Medical, Software
Innovation Industries
VC Fund
1 The Netherlands, Belgium, United States Seed, Series A Semiconductor, Manufacturing, Electronics $2M–$33M
Epimède SA
VC Fund
1 Belgium, The Netherlands Series B, Series C, Series D Biotechnology, Medical, Health Care $12M–$23M
WING by Digital Wallonia
VC Fund
1 Belgium Seed, Convertible Note, Series A Software, Health Care, SaaS $219k–$11M
VIVES Funds
VC Fund
1 Belgium, France, Switzerland Seed, Series A, Series B Biotechnology, Health Care, Therapeutics $2.9M–$57M
the SRIW Life Sciences
VC Fund
1 Belgium Series A, Series B Biotechnology, Medical, Biopharma $21M–$26M
European Investment Bank
VC Fund
1 France, Germany, The Netherlands Debt Financing, Post-IPO Debt Biotechnology, Health Care, Energy $16M–$658M
Seventure Partners
VC Fund
1 France, United States, Germany Series A, Series B Biotechnology, Health Care, Software $3.1M–$65M
Kenneth Buckfire
Angel
1 Belgium Series A Medical, Health Care, Life Science
Newton Biocapital
VC Fund
1 Belgium, Japan, France Series A, Seed Biotechnology, Medical, Health Care $2.7M–$84M
Nivelinvest
VC Fund
1 Belgium, United States Series A, Seed Biotechnology, iOS, Sports $6.6M–$31M
Novo Nordisk
VC Fund
1 United States, Denmark, Canada Seed, Series A, Series B Biotechnology, Health Care, Therapeutics $1.6M–$115M
UCB Ventures
VC Fund
1 United States, Belgium, Spain Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $1.8M–$135M
SFPI-FPIM
VC Fund
1 Belgium, United States, The Netherlands Series B, Series A Health Care, Biotechnology, Medical $4.4M–$75M
Access all 70 investors in Belgium Life Science startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Meusinvest (Noshaq)
VC Fund · Liège, Liege, Belgium · 6 investments in Belgium Life Science startups

Noshaq offers financial services to help businesses develop.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Seed
  • Geography: Belgium, France, Germany

Investor stats

  • Total investments: 76
  • Round size: Seed $137k–$6M; Series A $3.3M–$16M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • TrustUp — TrustUp is the home contractors platform, connects homeowners with verified quality home improvement.
  • Le Fourgon — Le Fourgon provides contained drinks for home delivery. They offer milk, water, beer, wine, fruit juice, and sodas. They allow customers to have their drinks delivered free of charge during the day.
  • Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Show all investments...

PMV
VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 5 investments in Belgium Life Science startups

Do and dare company

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Series A, Seed
  • Geography: Belgium, United States, The Netherlands

Investor stats

  • Total investments: 147
  • Round size: Seed $549k–$4.3M; Series A $2.7M–$40M
  • Lead/follow: 22% lead, 78% follow

Portfolio highlights

  • Sentea — Sentea makes fibre optic Sensing affordable to the industry and enables continuous monitoring even in harsh environments.
  • RheaVita — Streamline your lyophilization process with RheaVita's innovative freeze-drying technologies, accelerating drug development while ensuring compliance and efficiency. Discover our solutions today.
  • Gorilla — We empower Energy Retailers in pricing, forecasting and reporting with data-driven solutions in boosting speed and flexibility.
Show all investments...

Qbic Fund
VC Fund · Belgium, Wisconsin, United States · 4 investments in Belgium Life Science startups

The Qbic Fund is a multi-sector fund supporting spin-off companies of the Ghent, Brussels and Antwerp university associations and of VITO. Through its strategic partnership with the universities of Ghent, Brussels and Antwerp, and VITO, the Qbic Fund has early and privileged access to promising research projects at these partner universities. Ourinvestment approach is based on early in-depth and independent review and analysis followed by hands on involvement and support.In May 2012 the Qbic Fund held its first close and currently it has over € 30 million under management. The Qbic Fund is backed by several public and private investors and managed by Qbic Venture Partners.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Seed, Series A
  • Geography: Belgium, The Netherlands

Investor stats

  • Total investments: 54
  • Round size: Seed $1.1M–$11M; Series A $868k–$47M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: Likely still investing — raised $57M in 2022

Portfolio highlights

  • Aloxy — Aloxy offers reliable IIot solutions tailored to the needs of the process industry. Our valve sensor provides an open and close indication of manual valves.
  • Flindr Therapeutics — Immagene develops personalized cancer immunotherapies to fight multiple cancer type.
  • Blue Foot Membranes — Blue Foot Membranes delivers unbreakable MBR membranes for wastewater treatment. Reliable water reuse, high capacity and low total cost of ownership.
Show all investments...

Limburgse Reconversie Maatschappij
VC Fund · Hasselt, Limburg, Belgium · 3 investments in Belgium Life Science startups

Oxygen for growth - LRM

Show more...

Investment focus

  • Industry: Information Technology, Software, Biotechnology
  • Stage:Seed, Series A
  • Geography: Belgium, United States, The Netherlands

Investor stats

  • Total investments: 87
  • Round size: Seed $494k–$5.2M; Series A $1.6M–$11M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • ADLC — ADLC employs drone technology to deliver logistics services, allowing businesses to implement drone-based solutions without having to manage them in-house. The company is focused on enhancing last-mile delivery in maritime and offshore environments. ADLC now conducts drone delivery services in the Port of Antwerp in collaboration with SGS, atesting and certification company, and works with companies such as BASF. Its drones have reduced delivery times and environmental effect, boosting efficiency sixfold and lowering CO2 emissions by up to 80% for petrochemical sample deliveries.
  • MobieTrain — Train, connect and empower your frontline teams in minutes. MobieTrain boosts onboarding, training, engagement, and performance. All in one simple platform
  • TrendMiner — TrendMinder designs and delivers a fast, powerful and intuitive industrial analytics platform for everyone in operations to make smarter, data-driven decisions.
Show all investments...

Sambrinvest
VC Fund · Gosselies, Hainaut, Belgium · 3 investments in Belgium Life Science startups

Sambrinvest is an active venture capital player in the region of Charleroi - Thuin.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A, Series B
  • Geography: Belgium, France, Spain

Investor stats

  • Total investments: 39
  • Round size: Seed $544k–$24M; Series A $411k–$57M; Series B $4.4M–$44M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Sunrise — Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate asin-lab sleep studies, at a fraction of the cost.Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.
  • Vertical Compute — Vertical Compute offers chiplet-based technology that cuts data movement to achieve up to 80% energy savings.
  • Enodia Therapeutics — Enodia Therapeutics pioneers targeted protein degradation at the Sec61 translocon, developing small-molecule therapies for inflammatory and autoimmune diseases.
Show all investments...

S.R.I.W.
VC Fund · Liège, Liege, Belgium · 3 investments in Belgium Life Science startups

The S.R.I.W. Group is an institution at the heart of the financial market that assists entrepreneurs in creating and developing businesses in the Walloon region. It reflects the effort of Wallonian industry in facing the challenges of the creation of economic value in the 21st century. Since its creation in 1979, the Société Régionaled’Investissement de Wallonie has continuously been expanding its abilities to adapt and anticipate as well as its flexibility in order to meet the requirements of its partners who are confronted with the evolution of the world economy. The principles of good governance, a strong business culture and shared values at the heart of the Group constitute important assets to capture the changing realities of the market and progress in a sustainable development perspective.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Manufacturing
  • Stage:Series A, Series B
  • Geography: Belgium, United States, Spain

Investor stats

  • Total investments: 111
  • Round size: Series A $411k–$31M; Series B $1.6M–$75M
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • Intressa Vascular — Intressa Vascular provides innovative solutions to address life-threatening cardiovascular conditions such as aortic dissection.
  • Minoryx Therapeutics — Minoryx is focused on the discovery and development of novel treatments for severe, orphan diseases of the central nervous system with high unmet medical need.
  • Santero Therapeutics — This is the homepage of the website
Show all investments...

Theodorus III
VC Fund · 3 investments in Belgium Life Science startups

Theodorus is the spin-off fund of Université Libre de Bruxelles that invests ininvest in early stage projects based on proprietary disruptive technologies.

Show more...

Investment focus

  • Industry: Health Care, Life Science, Medical
  • Stage:Seed, Series A
  • Geography: Belgium, Canada, France

Investor stats

  • Total investments: 13
  • Round size: Seed $3.7M–$11M; Series A $2.2M–$6.6M
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • DrugBank — DrugBank augments human intelligence to improve the world’s health. Our suite of products are powered by the world’s most complete and up-to-date pharmaceutical knowledge database. It includes everything there is to know about drugs and how they work in the body. We enable companies to improve healthcare delivery through precision medicine orclinical software applications, as well as uncover insights through data science in drug discovery. Our knowledge base can be integrated into software solutions to help achieve clinical intelligence. Companies can easily scale their usage through our API and launch faster with flexible data modules. By providing users with advanced insights and the right information at the right time, users are empowered to make better health decisions.Our extensive, structured datasets are used to discover novel drug candidates, identify drug repurposing opportunities, and build predictive machine learning models. Companies working with data science can find answers quickly and get drugs to market faster with our evidence-based drug information. Lastly, our publicly available resource, DrugBank Online, is free-to-use with limited datasets available for download for academic and non-commercial researchers. DrugBank has been cited in over 13,000 academic publications and is used by millions of researchers and health professionals globally.
  • HYPNO VR — HypnoVR is a virtual reality software for anesthesia, treatment of pain, and anxiety. It was founded in 2016 and is based in Strasbourg, France.
  • Cascador Health — Cascador Health bridges the gap between sources and users of healthcare data. Using curated, validated and anonymized RWD allows healthcare providers and life science industry to gain insights and provide better care.
Show all investments...

V-Bio Ventures
VC Fund · Gent, Oost-Vlaanderen, Belgium · 2 investments in Belgium Life Science startups

V-Bio Ventures is an independent venture capital firm specialized in building and financing young, innovative life science companies. The fund invests throughout Europe in start-up and early-stage companies with high growth potential focusing on technologies that provide transformational improvements in the biotech, pharmaceutical and agriculturalsectors.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: Belgium, France, United States

Investor stats

  • Total investments: 40
  • Round size: Seed $3.2M–$50M; Series A $6.6M–$73M; Series B $12M–$88M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: May invest from a new fund soon — raised $129M in 2021

Portfolio highlights

  • Biodol Therapeutics — Biodol Therapeutics, founded in 2015, develops first-in-class compounds for the treatment of chronic pain (CP). Biodol Therapeutics has identified the Receptor Tyrosine Kinase (RTK) FLT3 as a key player for triggering and maintaining the chronic neuropathic pain (NP) state. New findings from Biodol Therapeutics' academic partnership (CyrilRivat and Jean Valmier at the INSERM Institute for Neurosciences in Montpellier) also demonstrated that FLT3 inhibition increases the potency of opioids for their analgesic effect, and hereby reduces their safety risks, especially addiction risk, which will help fighting the Opioid Crisis. The development of extracellular inhibitors of the FLT3 receptor, is a proprietary and key approach developed by Biodol Therapeutics.
  • Augustine Therapeutics — Augustine Therapeutics is developing selective, safe and efficacious HDAC6 inhibitors designed for treatment of neuromuscular, neurodegenerative and cardiometabolic diseases. Discover our pipeline poised for clinical impact.
  • Corteria Pharmaceuticals — Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations, focused on the development of transformative therapies for the treatment of worsening and acute decompensated heart failure.
Show all investments...

Mérieux Equity Partners
VC Fund · Lyon, Rhone-Alpes, France · 2 investments in Belgium Life Science startups

Mérieux Equity Partners (“MxEP”) is a management company dedicated to venture, growth and LBO investments in the healthcare and nutrition sectors. MxEP actively supports entrepreneurs and industrial companies with differentiated products and services, by providing privileged access to its expertise and international network. MxEP currently managesmore than €600m AUM and has recently launched a new vehicle MP3 of €350m dedicated to growth/LBO.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Series A, Private Equity
  • Geography: France, United States, Belgium

Investor stats

  • Total investments: 57
  • Round size: Series A $5.8M–$22M; Private Equity $22M–$150M
  • Lead/follow: 37% lead, 63% follow
  • Last fund: May invest from a new fund soon — raised $417M in 2020

Portfolio highlights

  • DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
  • Ceva Santé Animale — Ceva Sante Animale S.A. engages in the research, development, production, and marketing of pharmaceutical products and vaccines for companion and farm animals. They work with welfare and social programmes around the world to bring this vision to life – anywhere their products and know-how can make a difference and with all kinds of partners. FromUganda, working with small-scale livestock owners and vets to stop sleeping sickness in its tracks, to the UK and USA, where they supply the biggest animal welfare charities with Adaptil® collars to help re-home shelter dogs.
  • CorFlow Therapeutics — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.
Show all investments...

Annie Vereecken
Angel · Antwerp, Antwerpen, Belgium · 2 investments in Belgium Life Science startups

Annie Vereecken

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Hospital
  • Stage:Seed, Series A
  • Geography: Belgium

Investor stats

  • Total investments: 7
  • Round size: Seed $2M–$6M; Series A $8.2M–$27M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • Ziphius — Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.
  • Sensolus — Sensolus provides care-free tracking of your valuable non-powered assets directly from the cloud.Sensolus offers turnkey solutions for wireless, low-power context-aware sensing. Sensolus developed a personal product line of low-power tracker systems called STICKNTRACK.Sensolus is built upon many years of expertise in low-power networks,wireless sensor design, cloud-based sensor management, analytics, and applications.
  • Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Innovation Fund
VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 2 investments in Belgium Life Science startups

Chemical, Advanced Materials, Cosmetics, Recycling, CleanTech, Plastics and Rubber Manufacturing, Nanotechnology, Biosciences

Show more...

Investment focus

  • Industry: Health Care, Manufacturing, Information Technology
  • Stage:Seed, Series A
  • Geography: Belgium, France, Luxembourg

Investor stats

  • Total investments: 30
  • Round size: Seed $329k–$5.8M; Series A $2.2M–$5.7M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • Aerosint — Aerosint invented a technology called "Selective Powder Deposition" which deposits multiple powders in each layer. This unlocks multi-material 3D printing.
  • Daphne Technology — Measure and abate methane slip with Daphne Technology. Learn how we reduce emissions in gas engine exhaust. Contact us today!
  • Zeopore Technologies — Zeopore Technologies innovates zeolite mesoporization to optimize catalysts that enhance processes in refining and petrochemical industries. This leads to higher quality products, lower energy use and less waste, using an approach that is affordable, easily scalable and non-hazardous.
Show all investments...

Pierre Drion
Angel · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 2 investments in Belgium Life Science startups

Pierre Drion - CEO @ Petercam

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Life Science
  • Stage:Series A, Series B
  • Geography: Belgium

Investor stats

  • Total investments: 5
  • Round size: Series A $8.8M–$14M; Series B $18M–$26M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • A-Mansia Biotech — A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering theintestinal epithelium, which allows the bacterium to establish a close cross-talk with the host.
  • Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
  • Santero Therapeutics — This is the homepage of the website
Show all investments...

VIB
VC Fund · Gent, Oost-Vlaanderen, Belgium · 2 investments in Belgium Life Science startups

Strategic research in on life sciences and biotechnology

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: Belgium, Brazil, Denmark

Investor stats

  • Total investments: 23
  • Round size: Seed $3.2M–$4.6M; Series A $6.8M–$84M; Series B $4.4M–$65M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Animab — Animal Health Company
  • Biotalys — Biotalys is an Agricultural Technology (AgTech) company that employs its proprietary Agrobody technology platform to develop crop and food protection products. The company develops a new generation of protein-based biocontrol solutions, shaping the future of sustainable and safe food supply. Biotalys' unique protein-based biocontrols combinethe high-performance characteristics of chemicals with the clean safety profile of biologicals, making them ideal crop protection agents for both pre- and post-harvest applications.It was incorporated in 2013 and is based in the Biotech hub in Ghent, Belgium.
  • MRM Health NV — MRM Health NV, is a biopharmaceutical company focused on the discovery and development of innovative therapeutics based on the human microbiome. MRM Health was incorporated early 2020 by MRM Technologies, a Center of Expertise for microbiome research based in the biotech cluster in Ghent, in a joint venture with the Flemish Institute ofBiotechnology (VIB), an excellence-based entrepreneurial life sciences research institute in Flanders, Belgium, that focuses on translating basic scientific results into pharmaceutical, agricultural and industrial applications.
Show all investments...

New Science Ventures
VC Fund · New York, New York, United States · 2 investments in Belgium Life Science startups

New Science Ventures is a venture capital firm that focuses on investments in life sciences and information technology companies. They invest in early and late stage companies taking novel scientific approaches to address significant unmet needs, while creating order-of-magnitude improvements in performances. The company also invests in companiesusing science-based innovations to address market needs in life sciences such as pharmaceuticals, biologics, medical devices, diagnostics, and IT. The team of the company expertise in strategy and corporate planning, operations and cost management, and leadership development.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A
  • Geography: United States, United Kingdom, Belgium

Investor stats

  • Total investments: 85
  • Round size: Series A $4M–$49M; Series B $8M–$52M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: May invest from a new fund soon — raised $4.9M in 2020

Portfolio highlights

  • BrightVolt — BrightVolt is an innovative manufacturer of solid-state thin & flexible lithium polymer batteries and power-efficient thin & flexible microelectronics for IoT clients. It specializes in the fields of battery, electronics, and manufacturing. BrightVolt got recapitalization in November 13, 2013.
  • Morrow Optics — Looking for the next big thing in eyewear technology? Check out Morrow's electrified progressives, also known as autofocals! These innovative glasses switch focus length with a touch of button, providing you with seamless vision from near to far. Learn more about this technology on Morrow's website.
  • NorthSea Therapeutics — NorthSea Therapeutics B.V. is a Dutch biotech company developing novel and innovative strategies for the treatment of non-alcoholic steatohepatitis (NASH) and other metabolic, cholestatic and fibrotic diseases.
Show all investments...

Luc Vauterin
Angel · 2 investments in Belgium Life Science startups

Luc Vauterin - Board Member @ ONTOFORCE

Show more...

Investment focus

  • Industry: Life Science, Data Integration, Data Visualization
  • Stage:Seed, Series A
  • Geography: Belgium

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • ONTOFORCE — ONTOFORCE creates and implements pioneering semantic search technology for information management. Our user-friendly data search platform DISQOVER builds uniquely intelligent links between heterogeneous data sources, allowing everybody to become a data scientist.
Show all investments...

Industrya
VC Fund · Seraing, Liege, Belgium · 1 investments in Belgium Life Science startups

We are a hands-on investment fund that operates exclusively in the Industry 4.0, energy and new materials sectors. Industrya is an initiative of the John Cockerill industrial group, which joins together the investment funds of SFPI-FPIM, SRIW-WING, NOSHAQ and LRM.

Show more...

Investment focus

  • Industry: Industrial, B2B, SaaS
  • Stage:Seed, Series A
  • Geography: France, Belgium

Investor stats

  • Total investments: 12
  • Round size: Seed $1.1M–$4.4M; Series A $3.3M–$6.7M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • Aloxy — Aloxy offers reliable IIot solutions tailored to the needs of the process industry. Our valve sensor provides an open and close indication of manual valves.
  • Qviro — Your go-to source for the latest robotics news, expert insights & product comparisons on AI humanoids & industrial automation. Stay ahead on Qviro.com.
  • Zozio — Zozio provides logistic flow optimization, stock optimization, workplace environment, sustainable production, track, and trace services.
Show all investments...

Piet Van Waes
Angel · Ghent, Oost-Vlaanderen, Belgium · 1 investments in Belgium Life Science startups

Piet Van Waes is the Managing Director and Founder of Tilleghem. He previously worked at Green Park Investment Partners as a Partner. Piet Van Waes attended KU Leuven.

Show more...

Investment focus

  • Industry: Hotel, Medical, Tourism
  • Stage:Seed, Pre-Seed
  • Geography: Belgium

Investor stats

  • Total investments: 4
  • Round size: Seed $1M–$2.4M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Rookoo — Rookoo is an AI-driven venue management software that talks to your customers, handles the intake, checks availability, fills your CRM or booking software, and hands off to your team for seamless follow-up.
  • Tinrate — Tinrate is an easy-to-use connection that allows instructors, experts, and artists to be booked and paid immediately for their services. It serves as a link between your audience and your bank account rather than being a platform full of
  • Exhibitly.ai — Exhibitly.ai provides an AI‑powered platform for trade shows and B2B conferences that personalizes visitor experiences on event websites. Generates tailored exhibitor and session recommendations using attendee job title and company inputs. Converts anonymous website traffic into higher‑intent leads for event organizers.
Show all investments...

Jürgen Ingels
Angel · Antwerp, Antwerpen, Belgium · 1 investments in Belgium Life Science startups

Jurgen Ingels is the Founder and Managing Partner of SmartFin. He previously worked at FTI SuperNova as an Organizer. Jurgen holds a Master's degree in Political and Social Sciences and an MBA from the University of Antwerp.

Show more...

Investment focus

  • Industry: Software, Analytics, SaaS
  • Stage:Seed, Series B, Series A
  • Geography: Belgium, Turkey, The Netherlands

Investor stats

  • Total investments: 18
  • Round size: Seed $2.4M–$3M; Series A $3.3M–$12M; Series B $5.3M–$35M
  • Lead/follow: 61% lead, 39% follow

Portfolio highlights

  • MariaDB — MariaDB provides open source database and database as a service (DBaaS) solutions to support scalability, mission-critical deployments, and more.
  • Casper — Casper is a pan European Hybrid Kitchen pioneer and a modern day food hall; 100% virtual and getting everyone what they want. Their vision is to have a foothold in every great city of Europe: a virtual food hall (referring to the wide variety of cuisines available from which you can order) at everyone’s fingertips, from the comfort of their ownhome. Available for in-store purchase, pick-up or within 30 minutes delivery distance. Similar to a dark kitchen, Casper's kitchen operations are takeaway & delivery focused. However, they differ by choosing high street locations where customers are able to walk in and order from a kiosk, click & collect or pick-up from the deli. While they wait for and see how their food is prepared, the branded in-store environment allows them to engage with the brand; completely wiping out the mystery-factor and all misconceptions around ghost kitchens.
  • Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Show all investments...

Sofinnova Investments
VC Fund · Menlo Park, California, United States · 1 investments in Belgium Life Science startups

Sofinnova deploys human and financial capital to turn dreams into drugs. We are a clinical-stage biopharmaceutical venture capital firm with approximately $2B in assets under management and committed capital.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series B, Series A, Series C
  • Geography: United States, France, Switzerland

Investor stats

  • Total investments: 210
  • Round size: Series A $7.3M–$100M; Series B $15M–$137M; Series C $15M–$94M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: May invest from a new fund soon — raised $650M in 2016

Portfolio highlights

  • Invitae — Invitae and Labcorp together offer advanced genetic testing that can be easily integrated into medical practices. Improve patient care with meaningful insights based on DNA.
  • Vera Therapeutics — Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential. The company's gene-editing technology can potentially cure patients with sickle cell disease, cystic fibrosis, and other devastating genetic disorders, enabling physicians to improve gene detection and regulation.
  • Aeovian Pharmaceuticals — Aeovian is a San Francisco based biopharmaceutical company developing novel and highly selective therapeutics modulating mTORC1 pathway.
Show all investments...

Evren Ucok
Angel · Istanbul, Istanbul, Turkey · 1 investments in Belgium Life Science startups

Evren Ucok is a co-founder and investor at Peak Games, an interactive social game development platform. He is also a partner at Earlybird Venture Capital, an investment fund-based in Europe that focuses on emerging companies; Trendyol.com, a fashion e-commerce site; and Oliver Wyman.

Show more...

Investment focus

  • Industry: Medical, Health Care, Life Science
  • Stage:Series A
  • Geography: Turkey, Belgium

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • idemama — Idemama is an online platform that provides its users with web and graphic design services. It is based in Istanbul, Turkey.
  • Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
6K Venture Capital
VC Fund · 1 investments in Belgium Life Science startups

6K Venture Capital operates as a venture capital firm.

Show more...

Investment focus

  • Industry: Medical, Software, Health Care
  • Stage:Seed, Series A
  • Geography: Panama, Belgium

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Rise Of Defenders — Rise of Defenders is a very interesting Metaverse NFT game, you can use your creativity and tactical thinking to become an excellent player and receive extremely attractive rewards.
  • Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
Show all investments...

Capricorn Partners
VC Fund · Leuven, Vlaams-Brabant, Belgium · 1 investments in Belgium Life Science startups

Capricorn Partners is a unique independent manager of venture capital, growth capital and quoted equity funds

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Series A, Series B
  • Geography: Belgium, United States, The Netherlands

Investor stats

  • Total investments: 117
  • Round size: Series A $3.3M–$18M; Series B $5.3M–$42M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Azumuta — Unite Connected Worker and MES capabilities to build the execution platform that coordinates, governs, and continuously improves operational work on the shop floor, across humans, AI agents, and robotic systems
  • Sensolus — Sensolus provides care-free tracking of your valuable non-powered assets directly from the cloud.Sensolus offers turnkey solutions for wireless, low-power context-aware sensing. Sensolus developed a personal product line of low-power tracker systems called STICKNTRACK.Sensolus is built upon many years of expertise in low-power networks,wireless sensor design, cloud-based sensor management, analytics, and applications.
  • VOID Technologies — VOID Technologies is a groundbreaking materials science company spun out of Kimberly-Clark to commercialise the VO+ technology. Our business model is based on supplying VO+ additive masterbatches to film manufacturers.
Show all investments...

OBI SA
VC Fund · 1 investments in Belgium Life Science startups

OBI SA

Show more...

Investment focus

  • Industry: Life Science, Biotechnology, Health Diagnostics
  • Geography: Belgium

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Diagenode — Diagenode is an international life sciences company that develops and commercializes innovative instruments and reagents systems for life science research and molecular diagnostics. Founded in 2003 in Liege (Belgium), Diagenode is a global company, with headquarters in Liege, Belgium and Sparta, NJ, USA. Diagenode also has a local sales office inthe United Kingdom to better serve this specific country.Diagenode's customers include leading epigenetics researchers, academic institutions, high-profile genome centers and core labs, life sciences tools companies, molecular diagnostics players, and pharmaceutical and biotechnology companies.Epigenetics Division
Show all investments...

Fund+
VC Fund · Leuven, Vlaams-Brabant, Belgium · 1 investments in Belgium Life Science startups

Fund+ is a venture capital firm that invests in companies operating in the diagnostics, therapeutics, medical devices, and life science sectors. The firm wants to create sustainable shareholders' value, contribute to the development of a leadership position in the life sciences sector, and generate a tangible, beneficial societal impact.Fund+ was established in 2015 and is based in Leuven, Belgium.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: Belgium, United States, Spain

Investor stats

  • Total investments: 31
  • Round size: Series A $11M–$44M; Series B $21M–$125M; Series C $11M–$401M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • Indigo Diabetes — Revolutionizing the management of chronic disease.
  • Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
  • TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Show all investments...

BioGeneration Ventures
VC Fund · Naarden, Noord-Holland, The Netherlands · 1 investments in Belgium Life Science startups

Shaping new life-science ventures.

Show more...

Investment focus

  • Industry: Biotechnology, Therapeutics, Health Care
  • Stage:Series A, Seed
  • Geography: The Netherlands, United States, Belgium

Investor stats

  • Total investments: 62
  • Round size: Seed $1.1M–$50M; Series A $5.3M–$86M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: May invest from a new fund soon — raised $148M in 2021

Portfolio highlights

  • Dualyx — Dualyx engages in the discovery and development of biologicals for the treatment of autoimmune and rare diseases.
  • Citryll — Citryll is a private pharmaceutical company that develops pharmaceutical drugs used to treat autoimmune and other human diseases. The company offers formation, function, and clearance of NETs downstream of the protein citrullination pathway catalyzed by Peptidylarginine Deiminase (PAD) enzymes that enable doctors to help in the treatment of lupus,vasculitis, pulmonary fibrosis, rheumatoid arthritis and organ damage due to sepsis.Citryll was established in 2015 and is headquartered in Oss, The Netherlands.
  • Complement Therapeutics — Turning powerful new Complement System insights into innovative treatments Developing the next generation of complement medicines [chevron-down] Turning powerful new Complement System insights into innovative treatments Developing the next generation of complement medicines [chevron-down] Geographic atrophy (late dry age-related macular degeneration) is a chronic eye condition that affects millions - and for which there is
Show all investments...

invest.bw
VC Fund · Louvain-la-neuve, Vlaams-Brabant, Belgium · 1 investments in Belgium Life Science startups

invest.bw is a venture capital firm.

Show more...

Investment focus

  • Industry: Biotechnology, Manufacturing, Farming
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Belgium, United States

Investor stats

  • Total investments: 7
  • Round size: Seed $2.9M–$43M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • neuroClues — An easy-to-use eye-tracking environment to help practitioners instantaneously quantify their clinical exam
  • Vertical Compute — Vertical Compute offers chiplet-based technology that cuts data movement to achieve up to 80% energy savings.
  • ARK Capture Solutions — ARK Capture Solutions is a cleantech company that specializes in decarbonization solutions to record low energy consumption.
Show all investments...

Qbic
VC Fund · London, England, United Kingdom · 1 investments in Belgium Life Science startups

Qbic is the result of a lot of thinking, debating and sketching of what a city hotel could be; one that breaks the rules and makes people smile.An astonishing level of change has swept through the world over the last few years. But the hotel experience is no different than it’s ever been: stuffy, over-priced and lacking soul. They’re here tochange all that. they’re curious, imaginative and friendly, and they think there are lots of people just like us seeking a hotel with personality in the middle of the city.They believe in something better than what’s currently out there. A place that celebrates life rather than sucks life out of it. A hotel that’s built on creativity and a belief that you don’t have to accept the conventional. Somewhere that sends you away with fun stories and ideas, and is easy on your pocket.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, AgTech
  • Stage:Seed, Series B
  • Geography: Belgium

Investor stats

  • Total investments: 7
  • Lead/follow: no public data

Portfolio highlights

  • moveUP — Ontvang medische zorg op afstand voor en na uw operatie. moveUP is gespecialiseerd in de begeleiding van knie- en heupoperaties.
  • Axithra — Axithra provides therapeutic medication monitoring and measures beta-lactam antibiotic concentrations in blood.
  • Cascador Health — Cascador Health bridges the gap between sources and users of healthcare data. Using curated, validated and anonymized RWD allows healthcare providers and life science industry to gain insights and provide better care.
Show all investments...

Ifoghas Investments
VC Fund · 1 investments in Belgium Life Science startups

Ifoghas Investments operates as an investment firm.

Show more...

Investment focus

  • Industry: Medical, Health Care, Life Science
  • Stage:Series A
  • Geography: Belgium

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
Show all investments...

Nausicaa Ventures
VC Fund · Mont-saint-guibert, Brabant Wallon, Belgium · 1 investments in Belgium Life Science startups

A multi-industry early stage venture capital fund Nausicaa Ventures is an early stage investment fund organisation focused on investment rounds between EUR 1 and 4 million. Nausicaa Ventures was created in 2009 by bringing together 35 private investors and selected institutional investors, such as the European Investment Fund or ING Bank, under the management of ...

Show more...

Investment focus

  • Industry: Software, CRM, Big Data
  • Stage:Series B
  • Geography: Belgium

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • NGDATA — NGDATA is the consumer intelligence management solutions company that empowers enterprises seeking greater customer lifetime value to drive continuous, actionable insights to enable sales and increase customer loyalty.The company does this through its unique combination of Big Data management and machine learning technologies in a singleintegrated solution.Recently named one of Bank Systems and Technology Magazine’s “Top 7 Big Data Players to Watch,” NGDATA is headquartered in Ghent, Belgium with offices in New York City and San Francisco. The company provides solutions to data-driven sectors such as financial services, retail and media/publishing.
  • Ovizio — Ovizio develops digital holographic interferometric microscopy products. It builds 4D microscopic imaging devices and software based on digital holographic microscopy. Ovizio offers oLine 4D, a research and development, and diagnostic desktop device that is used without specific sample preparation, as well as with automatic compensation ofscratches or distortions on the sample support; iLine 4D, a multipurpose device for applications, such as inline or online flow monitoring or direct monitoring of cell cultures in bioreactors; and OsOne software for visualization, analysis, and archiving of images captured by the imaging devices. It also provides ILine F, a device that captures suspension cell culture process in real time; iLine M, an instrument that monitors cell confluence in multi layer vessels; iLine S, an equipment that monitors reproducibility of fragile cell; and QMod, a holographic and fluorescene microscopy. Scientists in the areas of pharmaceutical and biotech research and development use the products of Ovizio. Philip Mathuis and Serge Jooris founded it in 2009, with its headquarters in Brussels in Belgium.
Show all investments...

Fonds Vives II (University of Louvain, UCL)
VC Fund · 1 investments in Belgium Life Science startups

Fonds Vives II (University of Louvain, UCL)

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Seed
  • Geography: Belgium, United States

Investor stats

  • Total investments: 5
  • Round size: Series A $9.9M–$14M; Series B $6.6M–$75M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Virovet — Antiviral drugs and thermostable vaccines for livestock
  • Sunrise — Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate asin-lab sleep studies, at a fraction of the cost.Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.
  • ITeos Therapeutics — iTeos Therapeutics is pioneering the discovery and development of highly differentiated immuno-oncology therapeutics for cancer patients.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Vives Louvain Technology Fund
VC Fund · Louvain-la-neuve, Vlaams-Brabant, Belgium · 1 investments in Belgium Life Science startups

Vives is an interregional seed and early stage technology multi-sector fund. The new fund, initiated by UCLouvain, is a unique European inter-university fund having access to world class innovations from leading EU top universities.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B
  • Geography: Belgium, France, United States

Investor stats

  • Total investments: 25
  • Round size: Series A $491k–$46M; Series B $4.4M–$125M
  • Lead/follow: 4% lead, 96% follow
  • Last fund: May invest from a new fund soon — raised $37M in 2020

Portfolio highlights

  • Sunrise — Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate asin-lab sleep studies, at a fraction of the cost.Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.
  • Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
  • Syndesi Therapeutics — Science that Builds Connections
Show all investments...

Annemie Van de Casteele
Angel · 1 investments in Belgium Life Science startups

Annemie Van de Casteele is a former member of the Belgian Parliament.

Show more...

Investment focus

  • Industry: Medical, Life Science, Biotechnology
  • Stage:Seed
  • Geography: Belgium

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • 4Tissue — Shaping the Future of Regenerative Medicine
Show all investments...

Virginie Saverys
Angel · 1 investments in Belgium Life Science startups

Virginie Saverys is a entrepreneur.

Show more...

Investment focus

  • Industry: Medical, Life Science, Biotechnology
  • Stage:Seed
  • Geography: Belgium

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • 4Tissue — Shaping the Future of Regenerative Medicine
Show all investments...

Griet Nuytinck
Angel · 1 investments in Belgium Life Science startups

Griet Nuytinck is founder of Anacura.

Show more...

Investment focus

  • Industry: Medical, Life Science, Biotechnology
  • Stage:Seed
  • Geography: Belgium

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • 4Tissue — Shaping the Future of Regenerative Medicine
Show all investments...

Opdorp Finance BVBA
VC Fund · 1 investments in Belgium Life Science startups

Opdorp Finance BVBA

Show more...

Investment focus

  • Industry: Life Science, Data Integration, Data Visualization
  • Stage:Series A
  • Geography: Belgium

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • ONTOFORCE — ONTOFORCE creates and implements pioneering semantic search technology for information management. Our user-friendly data search platform DISQOVER builds uniquely intelligent links between heterogeneous data sources, allowing everybody to become a data scientist.
Show all investments...

Korys
VC Fund · Halle, Vlaams-Brabant, Belgium · 1 investments in Belgium Life Science startups

Korys is the name chosen by the Colruyt family for their investment structure. The name Korys is derived from the Latin word for hazelnut tree – Corylus - which is at the origin of the Colruyt name.Their multi-disciplinary approach enables us to create a well-balanced, diversified portfolio of listed stocks and bonds, private equity funds, anddirect participations in small and medium-sized companies. Through their investments, they aim to make a positive impact on people and the planet, while generating attractive returns. A “three P” approach (People, Planet, Profit) forms the cornerstone of their investment strategy. They invest for the long term, as they realize that it takes time to achieve the sustainable impact they are aiming for. They focus their investments in sectors in which they have built substantial expertise as a team: Cleantech, consumer goods & retail and life sciences.

Show more...

Investment focus

  • Industry: Biotechnology, Renewable Energy, Information Technology
  • Stage:Series B, Series A
  • Geography: Belgium, The Netherlands, Germany

Investor stats

  • Total investments: 44
  • Round size: Series A $3.9M–$110M; Series B $6.4M–$41M
  • Lead/follow: 48% lead, 52% follow

Portfolio highlights

  • Trunkrs — Wij leveren pakketten tussen 17:00 & 22:00, Sneller, groener en vriendelijker. Same Day & Next Day bezorging door heel Nederland en Vlaanderen.
  • Ampacimon — Ampacimon develops dynamic line rating systems for transmission and distribution systems operators. Ampacimon’s products address grid infrastructure challenges such as aging assets, transmissions congestion, renewable integration, interconnectors.
  • Commit Biologics — Add a description for facebook
Show all investments...

Smedvig
VC Fund · Stavanger, Rogaland, Norway · 1 investments in Belgium Life Science startups

Venture Capital firm based in London. We help enable business funding though capital investment. In turn, that funds and drives business growth as exceptional speed. Visit our site to find out how our proven model of business investment can help your start up.

Show more...

Investment focus

  • Industry: Mining, Medical, Software
  • Stage:Series A, Series C
  • Geography: Belgium, Romania, South Africa

Investor stats

  • Total investments: 3
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Druid AI — DRUID is an AI platform that allows companies to automate processes by designing and deploying UiPath RPA integrated chatbot virtual assistants.
  • Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
  • Sedibelo Resources — Sedibelo Resources is a developing producer of platinum group metals (PGMs), is active in the acquisition, exploration for, and development and operation of deposits
Show all investments...

Innovation Industries
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 1 investments in Belgium Life Science startups

Innovation Industries is a Dutch venture capital fund investing in impactful deep tech, focusing on sustainability, scalability, and ESG-aligned companies.

Show more...

Investment focus

  • Industry: Semiconductor, Manufacturing, Electronics
  • Stage:Seed, Series A
  • Geography: The Netherlands, Belgium, United States

Investor stats

  • Total investments: 76
  • Round size: Seed $2M–$12M; Series A $6.3M–$33M
  • Lead/follow: 51% lead, 49% follow
  • Last fund: Likely still investing — raised $204M in 2023

Portfolio highlights

  • Aphea.Bio — Driving the revolution in biologicals
  • Orbem — Transform biological imaging with AI-powered MRI technology. Non-invasive solutions for poultry, fruits, nuts, and health. Building a sustainable future.
  • Arycs Technologies — EFFECT Photonics produces components for fibre optic networks based on photonic chip technology, originally developed at Eindhoven University of Technology. The unique chip technology from EFFECT Photonics delivers high communication speeds for low costs and low energy consumption. EFFECT Photonics products are used to connect mobile networktransmitters to the rest of the Internet and to connect data centres. With the technology of EFFECT Photonics, the capacity of existing fibre optic networks can be increased without having to install additional cables. EFFECT Photonics has offices in Eindhoven Netherlands, Great Britain and Taiwan and an international network of sales partners.
Show all investments...

Epimède SA
VC Fund · 1 investments in Belgium Life Science startups

Epimède SA

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series B, Series C, Series D
  • Geography: Belgium, The Netherlands

Investor stats

  • Total investments: 5
  • Round size: Series B $12M–$23M
  • Lead/follow: 40% lead, 60% follow

Portfolio highlights

  • Imcyse — Imcyse is a clinical stage biopharmaceutical company pioneering the development of a new class of active specific immunotherapies for the treatment of severe chronic autoimmune diseases. The company’s unique technology platform allows it to locally target immune cells involved in the destruction of the diseased organ. This platform is based on theadministration of Imotopes™, which are specifically modified peptides, allowing for the generation of cytolytic CD4 T-cells, that specifically eliminate antigen-presenting cells and autoantigen specific lymphocytes. Imcyse’s approach, sustained over time, helps to prevent and treat diseases with no current therapeutic alternative and to potentially cure patients without impairing immune defense. The company has established proof of concept in several indications and has completed its first clinical trial in type 1 diabetes with promising results. Beyond type 1 diabetes, Imcyse is developing a pipeline of Imotopes™ for the treatment of several autoimmune diseases.
  • Ncardia — At Ncardia, we believe that human stem cell technology will help get better therapies to patients faster.
  • Endo Tools Therapeutics — Endo Tools Therapeutics is dedicated to the development of innovative devices that provide therapeutic interventions for gastric conditions
Show all investments...

WING by Digital Wallonia
VC Fund · Liège, Liege, Belgium · 1 investments in Belgium Life Science startups

W.IN.G by Digital Wallonia invests in SAAS, advanced tech and deep tech startups (AI, drones, medtech, IOT,...). W.IN.G brings smart money by helping startups by bi-weekly interactions and providing an operating teams (seasonal entrepreneurs being hands-on with the portfolio).

Show more...

Investment focus

  • Industry: Software, Health Care, SaaS
  • Stage:Seed, Convertible Note, Series A
  • Geography: Belgium

Investor stats

  • Total investments: 34
  • Round size: Seed $346k–$1.9M; Series A $1.1M–$11M; Convertible Note $219k–$568k
  • Lead/follow: 26% lead, 74% follow

Portfolio highlights

  • IONNYK — IONNYK is a new medium of art photography, containing millions of tiny ink capsules.
  • MYOCENE — Myocene is a Liège-based sports technology company which creates unique and innovative devices for measuring muscle fatigue and performance.
  • Soil Capital Belgium — Discover Europe's first certified, multi-national carbon farming programme that rewards regenerative agriculture.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
VIVES Funds
VC Fund · Wavre, Brabant Wallon, Belgium · 1 investments in Belgium Life Science startups

VIVES is a seed capital fund initiated by UCLouvain which invests in companies developing disruptive innovations with a positive societal impact.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Seed, Series A, Series B
  • Geography: Belgium, France, Switzerland

Investor stats

  • Total investments: 8
  • Round size: Seed $2.9M–$5M; Series A $18M–$57M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • Generare — Generare decodes microbial genomes to generate novel, high-quality molecular data for drug discovery. 200+ new molecules characterized and growing.
  • Brightflow — Brightflow operates as a medical device startup.
  • Sunrise — Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate asin-lab sleep studies, at a fraction of the cost.Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.
Show all investments...

the SRIW Life Sciences
VC Fund · 1 investments in Belgium Life Science startups

the SRIW Life Sciences

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Biopharma
  • Stage:Series A, Series B
  • Geography: Belgium

Investor stats

  • Total investments: 3
  • Round size: Series B $21M–$26M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • A-Mansia Biotech — A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering theintestinal epithelium, which allows the bacterium to establish a close cross-talk with the host.
  • Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
Show all investments...

European Investment Bank
VC Fund · Luxembourg, Luxembourg, Luxembourg · 1 investments in Belgium Life Science startups

The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation, and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Energy
  • Stage:Debt Financing, Post-IPO Debt
  • Geography: France, Germany, The Netherlands

Investor stats

  • Total investments: 358
  • Round size: Post-IPO Debt $18M–$658M; Debt Financing $16M–$384M
  • Lead/follow: 80% lead, 20% follow

Portfolio highlights

  • Icosagen Group — Icosagen is an end-to-end Contract Research, Development & Manufacturing Organization. A science-driven partner for antibody, protein & biologics solutions.
  • Wandercraft — Self- balancing and hands free movement with the innovative self-balancing feature, Atalante allows for multi-tasking and cognitive involvement as part of treatments.
  • IPT PowerTech — IPT PowerTech coverage, coupled with our extensive expertise in supply chain management, field implementation, and power systems, has made us one of the most capable companies in handling the most complicated and versatile projects in the MEA region and its neighboring countries.
Show all investments...

Seventure Partners
VC Fund · Paris, Ile-de-France, France · 1 investments in Belgium Life Science startups

Seventure Partners is a French venture capital firm targeting in Tech/Digital and Life Sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with € 1 billion undermanagement as of December 31, 2023. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.The different funds/verticals on which Seventure Partners are focusing on today: - Life Sciences : Biotech, Healthcare, Nutrition - Tech/Digital : B2B SaaS, Fintech, Retailtech, Cybersecurity - Sports & Wellbeing - Blue Economy

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series A, Series B
  • Geography: France, United States, Germany

Investor stats

  • Total investments: 218
  • Round size: Series A $3.1M–$24M; Series B $3.3M–$65M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Sentryc — Protect your brand and your products from counterfeiters with Sentryc. We monitor over 120 marketplaces for you and remove potential counterfeits.
  • Flexvelop — Flexvelop combines financial technology with circular economy to add innovative values to the core function of equipment funding.Local vendors and online-shops integrate Flexvelop as a seamless embedded payment option. Business customers are now able to #flex new equipment per click right at the point of sale. Insurance is already covered, andour customers have now the weekly option, to buy- or return their equipment, easily. This enables a new world of worry-free and flexible business growth.We #flex business equipment from €300 up to €20.000 per item; e.g. coffee-machines, laptops, gym- or dental-equipment,... anything you need for your business.NEXT GENERATION PAYMENTS + Technological Innovation: fully automatic embedded payment option + Economical Innovation: optionality (rent/buy/return) + insurance included + Ecological Innovation: sustainability (contributing to a circular economy) = Enabling worry-free flexible business developmentForget renting. Forget leasing. Grow smart - flex it!
  • Vertero — Axial Therapeutics is a biotechnology company fundamentally changing the treatment of neurological diseases and disorders by harnessing groundbreaking science in the microbiome-gut-brain axis.
Show all investments...

Kenneth Buckfire
Angel · New York, New York, United States · 1 investments in Belgium Life Science startups

Kenneth Buckfire is the Chief Executive Officer at Miller Buckfire.

Show more...

Investment focus

  • Industry: Medical, Health Care, Life Science
  • Stage:Series A
  • Geography: Belgium

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
Show all investments...

Newton Biocapital
VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 1 investments in Belgium Life Science startups

Our mission is to mature innovation and support the growth of our portfolio companies to create value for patients, society, local ecosystems, and investors.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A, Seed
  • Geography: Belgium, Japan, France

Investor stats

  • Total investments: 21
  • Round size: Seed $2.7M–$3.2M; Series A $5.9M–$84M
  • Lead/follow: 67% lead, 33% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Bioxodes — Bioxodes is a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics to prevent thrombotic events without hemorrhagic risk.
  • Tensegrity Pharma — Tensegrity Pharma is the developer of a novel drug designed to minimize bottlenecks and provide innovative value to patients.
  • Augustine Therapeutics — Augustine Therapeutics is developing selective, safe and efficacious HDAC6 inhibitors designed for treatment of neuromuscular, neurodegenerative and cardiometabolic diseases. Discover our pipeline poised for clinical impact.
Show all investments...

Nivelinvest
VC Fund · Louvain-la-neuve, Vlaams-Brabant, Belgium · 1 investments in Belgium Life Science startups

Nivelinvest is a venture capital firm based in Belgium that finances seed stage investments of Small and Medium Enterprises.

Show more...

Investment focus

  • Industry: Biotechnology, iOS, Sports
  • Stage:Series A, Seed
  • Geography: Belgium, United States

Investor stats

  • Total investments: 6
  • Round size: Series A $6.6M–$31M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • e-peas — Discover e-peas, pioneer of the Ambient IoT concept since 2014, which offers the most efficient energy harvesting pmics on the market to make your devices more energy self-sufficient: AEMs.
  • A-Mansia Biotech — A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering theintestinal epithelium, which allows the bacterium to establish a close cross-talk with the host.
  • Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
Show all investments...

Novo Nordisk
VC Fund · Bagsværd, Hovedstaden, Denmark · 1 investments in Belgium Life Science startups

Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Seed, Series A, Series B
  • Geography: United States, Denmark, Canada

Investor stats

  • Total investments: 16
  • Round size: Seed $1.6M–$3.5M; Series A $5M–$12M; Series B $38M–$115M
  • Lead/follow: 44% lead, 56% follow

Portfolio highlights

  • Cellular Intelligence — Somite.ai is on a mission to transform the lives of millions of people by leveraging AI to produce human tissue for cell-based therapies.
  • Proton HeartPet — Proton HeartPet is the company in the field of pet intelligent medical care.
  • Aspect Biosystems — Pioneering the development of bioprinted tissue therapeutics to transform how we treat some of the most elusive diseases.
Show all investments...

UCB Ventures
VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 1 investments in Belgium Life Science startups

UCB Ventures is a €150 million strategic corporate venture fund

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, Belgium, Spain

Investor stats

  • Total investments: 19
  • Round size: Seed $1.8M–$6.6M; Series A $6.6M–$75M; Series B $9.4M–$135M
  • Lead/follow: 42% lead, 58% follow

Portfolio highlights

  • ViaNautis — Precision Solutions
  • Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
  • Neurona Therapeutics — Neurona Therapeutics is a pre-clinical stage biotechnology company that was founded by four neuroscientists and stem cell pioneers at The University of California, San Francisco. They are focused on the discovery and development of cell-based therapies to treat intractable neurological disease. Its initial aim is to generate therapeuticcompositions of a specific type of nerve cell (or neuron) for targeted delivery into the injured nervous system. Based on nearly two decades of research, they believe that particular subpopulations of neurons have the unique ability to integrate and repair dysregulated neural circuits. Its talented team of scientists, scientific advisors, and board directors is working to accelerate breakthrough treatments for patients with significant unmet medical needs.
Show all investments...

SFPI-FPIM
VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 1 investments in Belgium Life Science startups

The Federal Holding and Investment Company (SFPI-FPIM) centrally manages the federal government’s shareholdings, cooperates with the government on specific projects and pursues its own investment policy in the interests of the Belgian economy.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series B, Series A
  • Geography: Belgium, United States, The Netherlands

Investor stats

  • Total investments: 40
  • Round size: Series A $4.4M–$46M; Series B $11M–$75M
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • Cohabs — We create sustainable & community-driven shared homes around the world for young workers and interns. Join our community.
  • Axelera AI — Axelera AI is developing a game-changing hardware and software platform for AI.Incubated in 2019 by the emerging technologies leader Bitfury and joined by the leading nano-technology group imec in early 2020, Axelera AI launched as a new company in 2021. Headquartered in the AI Innovation Center of the High Tech Campus in Eindhoven, Axelera AIhas R&D offices in Belgium, Switzerland, and Italy. Its team of experts in AI software and hardware hail from top AI firms and Fortune 500 companies.
  • Tangent Works — Create predictive models in seconds for faster and better forecasting & anomaly detection with TIM InstantML.
Show all investments...

Life Science Investor funding in Belgium at a glance

Stats across 36 deals from 70 investors.

70
investors
in Belgium Life Science startups
36
deals
in Belgium Life Science startups
$4.7M
median round
in Belgium Life Science startups
34%
lead investors
lead at least one round
31%
Seed
most common funding stage
86/14
VC / Angel
share of investor count

Access all 70 investors in Belgium Life Science startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Life Science Investors in Belgium investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 70 investors investing in Belgium Life Science startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists